Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug--Long-acting Growth Hormone

Friday, May 31, 2024

Kexing Biopharm announced that Shenzhen Kexing Pharmaceutical Co Ltd its whollyowned subsidiary recently received a Notice of Approval for Drug Clinical Trials from the National Medical Products

OBiO Technology Officially Launched the Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases

Friday, May 31, 2024

OBiO Technology a world leading contract development and manufacturing organization for cell and gene therapy officially launched the Center for Clinical Evaluation and Translation of Advanced Therapies

Bayer and Burning Rock Collaborate to Increase Patient Access to Precision Cancer Medicines

Friday, May 31, 2024

Burning Rock Biotech Limited has recently announced a collaboration with Bayer to develop nextgeneration sequencing based companion diagnostic assays aiming to provide diagnostic methods

Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension

Friday, May 31, 2024

Gyre Therapeutics a clinicalstage selfsustainable biotechnology company developing antifibrotic therapeutics for a variety of chronic organ diseases today announced that the Center for Drug Evaluation

Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")

Thursday, May 30, 2024

Heron Therapeutics Inc a commercialstage biotechnology company today announced the Prior Approval Supplement submission to the US Food and Drug Administration

Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch

Thursday, May 30, 2024

Today Georgiamune Inc a privately held clinicalstage biotechnology company announced the clearance of its second Investigational New Drug application by the US Food and Drug Administration

Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment of ALS

Thursday, May 30, 2024

Spinogenix Inc a clinicalstage biopharmaceutical company pioneering firstinclass therapeutics that restore synapses to improve the lives of patients worldwide today announced that the US

Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty

Wednesday, May 29, 2024

Agios Pharmaceuticals Inc a leader in cellular metabolism and PK activation pioneering therapies for rare diseases announced that the company has agreed to sell its rights to its royalty on potential US net sales of Serviers vorasidenib to Royalty P...

Monash University and Thermo Fisher Scientific strengthen strategic collaboration

Wednesday, May 29, 2024

Marking an exciting new chapter in a longstanding relationship Monash University has entered into a Memorandum of Understanding with Thermo Fisher Scientific with the intention of accelerating scientific advancements fostering social responsibility a...

CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider

Wednesday, May 29, 2024

CorMedix Inc a biopharmaceutical company focused on developing therapeutic products for lifethreatening diseases and conditions today announced that it has entered into a multiyear commercial supply contract